Sensory System
Introduction to Sensory System
The sensory system is a key part of the nervous system that plays a significant role in transferring information derived from sensory organs. In general, the sensory system consists of chemical sense, vision, somatosensation, auditory and vestibular sensation. Moreover, pilot studies have demonstrated that the sensory system also contains a variety of sensory receptor cells, neural-related pathways, as well as brain sensory perception cells. Nowadays, the sensory system has been considered as a delivery system in the human body from the outside to the inside where we process information and create perceptions. In addition, the sensory system can detect a battery of internal and external stimuli, such as light, sound, or proprioceptors, and translates them into neural signals that can be interpreted by the nervous system.
Table 1. Sensory Systems.
Sensory Systems | Modality | Stimulus | Receptor Types | Receptor Cell-Types |
Visual | Vision | Light | Photoreceptors | Rods; Cones |
Auditory | Hearing | Sound | Mechanoreceptors | Hair Cells |
Vestibular | Balance | Gravity | Mechanoreceptors | Hair Cells |
Somatosensory | Somatic Senses; Touch; Pain; Temperature Sense; Itch | Pressure; Thermal; Mechanical | Mechanoreceptors; Chemoreceptors; Thermoreceptors; Mechanoreceptors | Dorsal Root Ganglion Neurons; Chemical Nociceptor; Polymodal; thermal; and mechanical nociceptors |
Gustatory | Taste | Chemical | Chemoreceptors | Taste Buds |
Olfactory | Smell | Chemical | Chemoreceptors | Olfactory Sensory Neurons |
Sensory System Development
In the past few decades, our understanding of the development of the sensory system in the fetus, infant and adult, has progressed. Meanwhile, many advanced technologies for revealing the development process of the sensory systems have also been generated and broadly used. Sensory system development usually occurs in the early stages of pregnancy, and most neurosensory development occurs between 16 and 20 weeks. Furthermore, the development of the sensory system also speeds up the maturation of organs such as the kidneys, stomach, lungs, heart and blood vessels, and the brain. Recent reports have indicated that the sensory system is connected and integrated with other systems, such as the motor system and the cognitive system, to achieve more functions.
Fig.1 The workflow of sensory systems. (Pérez Fornos, 2019)
Currently, a wide variety of sensory system receptor cells, including mechanoreceptors, photoreceptors, chemoreceptors, thermoreceptors, and pain receptors, have been extensively studied for detecting different types of stimuli. For instance, the olfactory neurons bind to its receptors that recognize odors, triggering electrochemical stimulation of the nervous system. These stimuli alter the membrane potential of sensory neurons and induce an action potential. Also, a range of therapeutic approaches, like stem cell therapy, has been established for treating various neurodegenerative diseases. Numerous data have suggested that sensory systems, including hearing and vision, have brought new hope for drug development against chemosensory disorders. Meanwhile, a series of novel therapeutic targets have been confirmed that may be potential intermediate players in the induction of sensory system-related diseases.
Therefore, Creative Biolabs is pleased to share our extensive expertise in the nervous system and facilitate our clients’ sensory system research and project development. If you do not find the specific service item you are looking for, please directly contact us. We can design and customize your project and generate the exact solution you need.
Reference
- Pérez Fornos, A.; et al. Designing artificial senses: steps from physiology to clinical implementation. Swiss medical weekly. 2019, 149: w20061.
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)